Not all innovation takes place in a lab. For Brad Malin, co-founder and chief executive officer of Companion CBD, true breakthroughs happen at the intersection of compassion and science. A visionary with a deep understanding of the human-animal bond, Malin has channeled years of professional experience into a company that’s changing lives—four-legged and two-legged alike. At the heart of Companion CBD is a mission to bridge veterinary medicine with natural wellness, driven by a commitment to education, accessibility and safety.
In just three years, Malin has guided the company through an extraordinary metamorphosis. Companion CBD has grown beyond simply offering products; it has become a resource trusted by veterinarians nationwide. Every advancement, from lab-tested formulations to continuing education programs, has been meticulously crafted to earn credibility in an industry often misunderstood. What sets Malin apart is his relentless focus on science as the foundation for trust.
His recent achievements reflect a powerful mix of advocacy and enterprise. Since earning recognition as a Titan 100 Honoree, Malin has successfully introduced a new veterinary-exclusive product line and deepened partnerships within the medical community. These developments are measured not just in sales, but in outcomes—dogs in less pain, families with renewed hope, clinicians with better tools.
Leadership, for Malin, means staying curious. He’s continually fueling his own growth by diving into data, emerging trends and customer feedback. This practice not only sharpens his strategy but also helps maintain the startup spirit that first launched Companion CBD. He recharges his passion through engagement—leading workshops, speaking with pet owners and exchanging knowledge with veterinarians.
The year’s most meaningful lesson came from listening. Malin has learned that feedback, even when challenging, offers invaluable perspective. Creating a culture where every voice is heard has driven innovation, improved team dynamics and elevated product development. He credits this approach with keeping Companion CBD agile and ethically grounded.
One of Malin’s most ambitious goals is fostering a next generation of ethical entrepreneurs in the wellness space. His mentorship efforts, from advising early-stage founders to participating in leadership accelerators, have built a ripple effect of impact. He gauges effectiveness by the sustainability of the businesses and the clarity of their missions—he wants to see values, not just ventures, thrive.
Asked what skill he would master instantly, Malin gravitates toward artificial intelligence. Not for automation’s sake, but to enhance predictive care and personalized solutions in veterinary medicine. He sees AI not as a replacement for expertise, but as a partner to deeper insight.
With each initiative, Malin continues to challenge the norms of an unregulated market, bringing standards and transparency where there were none. He’s not chasing disruption for its own sake; he’s building trust, one veterinarian, one pet, one result at a time. That’s what makes him not just a pioneer in his field, but a force that’s reshaping the future of care.
